menu
    • menu

    Company profile for TauRx Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    A leader in Alzheimer’s disease research, TauRx’s mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation. From initial discovery through preclinical development to clinical trials, regulatory submission and product registration, we are harnessing world-class proprietary drug discovery platforms with the ...
    A leader in Alzheimer’s disease research, TauRx’s mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation. From initial discovery through preclinical development to clinical trials, regulatory submission and product registration, we are harnessing world-class proprietary drug discovery platforms with the aim of halting the progression of Alzheimer’s and other neurodegenerative diseases with innovative treatments and diagnostics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TauRx TherapeuticsSingapore Flag
    Country
    Country
    Singapore
    Address
    Address
    3, Shenton Way, #21-04 Shenton House - 068805
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://taurx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/taurx-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/TauRx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TauRx Submits UK Marketing Authorization For HMTM As Alzheimer's Treatment
    TauRx Submits UK Marketing Authorization For HMTM As Alzheimer's Treatment

    01 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240701092104/en

    BUSINESSWIRE
    01 Jul 2024
    Share Share
    TauRx to Present Two-Year Data from Ph III Trial of HMTM in Alzheimer’s Disease
    TauRx to Present Two-Year Data from Ph III Trial of HMTM in Alzheimer’s Disease

    05 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240205168572/en

    BUSINESSWIRE
    05 Feb 2024
    Share Share
    Investors add $119m to TauRx’ kitty as tau drug filing nears
    Investors add $119m to TauRx’ kitty as tau drug filing nears

    14 Nov 2022

    // PHARMAPHORUM

    https://pharmaphorum.com/news/investors-add-119m-to-taurx-kitty-as-tau-drug-filing-nears/

    PHARMAPHORUM
    14 Nov 2022
    Share Share
    TauRx Announces Investment of USD119M & announcement of PIII LUCIDITY Results
    TauRx Announces Investment of USD119M & announcement of PIII LUCIDITY Results

    14 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/taurx-announces-additional-investment-of-usd119-million-following-announcement-of-phase-3-lucidity-topline-results-301676168.html

    PRNEWSWIRE
    14 Nov 2022
    Share Share
    TauRx's late-stage clinical trial reaches new milestone
    TauRx's late-stage clinical trial reaches new milestone

    14 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/taurxs-late-stage-clinical-trial-reaches-new-milestone-301525115.html

    PRNEWSWIRE
    14 Apr 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search